Get started
Author

Virginia Tan

Desmopressin as a hemostatic and blood sparing agent in bleeding disorders
2023 · Ajay Mohinani, Sarah Patel, et al. · European Journal Of Haematology · 31
PDF
CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia
2025 · Yannis K. Valtis, Chenyu Lin, et al. · Blood Advances · 4
PDF
Blinatumomab nonresponse correlates with poor survival after brexucabtagene autoleucel in B-cell ALL
2026 · Hrishikesh K. Srinagesh, Vishal Gupta, et al. · Blood · 3
Pre- or post-CAR-T allogeneic hematopoietic cell transplant provides relapse-free survival benefit for R/R Philadelphia negative B-cell acute lymphoblastic leukemia (B-ALL) successfully treated with brexucabtagene autoleucel in the real world
2025 · Aaron Logan, Fevzi Yalniz, et al. · Blood · 3
PDF
Patient characteristics, toxicity, and response after real world administration of obecabtagene autoleucel and brexucabtagene autoleucel for relapsed acute lymphoblastic leukemia: A rocca analysis
2025 · Yannis Valtis, Karamjeet Sandhu, et al. · Blood · 3
PDF
Unveiling the complexities of catheter-related thrombosis: risk factors, preventive strategies, and management
2025 · Hannah L. King, Thalia Padilla-Lazos, et al. · Journal of Thrombosis and Thrombolysis · 3
PDF
Impact of ABO compatibility on outcomes after allogeneic hematopoietic cell transplantation (HCT): increased risk of acute GVHD with ABO bidirectional mismatch, independent of traditional and emerging GVHD prophylaxis strategies
2025 · Yun Yu, Mikayla K. Murphy, et al. · Cytotherapy · 2
Real-world toxicity of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia
2025 · Noam E. Kopmar, Ted A. Gooley, et al. · Blood Immunology & Cellular Therapy · 1
Hypomethylating agent with venetoclax versus hypomethylating agent alone in frontline management of myelodysplastic syndrome - impact of subgroups on clinical outcomes
2025 · Guru Subramanian Guru Murthy, Yasmin Abaza, et al. · Blood · 1
PDF
Real-world performance of the CALGB 10403 regimen in young adults in the United States
2025 · Brandon DaSilva, Alicia Darwin, et al. · Blood Neoplasia · 1
KMT2Ar Adversely Impacts Brexucabtagene Autoleucel (Brexu-cel) Outcome in Adults with Relapsed/ Refractory (r/r) B-Cell Acute Lymphoblastic Leukemia.
2025 · Abdullah Ladha, Virginia Tan, et al. · Transplantation and Cellular Therapy · 1
Tyrosine Kinase Inhibitor (TKI) Maintenance Improves Remission Durability in Philadelphia-Chromosome Acute Lymphoblastic Leukemia (Ph+ ALL) Following Brexucabtagene Autoleucel (Brexu-cel)
2025 · Tamer Othman, Vinod Pullarkat, et al. · Transplantation and Cellular Therapy · 1
The impact of hematology electronic consultations on the management of iron deficiency
2024 · Hannah L. King, Genevieve B. Benedetti, et al. · European Journal Of Haematology · 1
Effect of Sirolimus on Vascular Malformations in Adult Populations
2023 · Virginia Tan, Emma P Deloughery, et al. · Blood · 1
PDF
Improved outcomes with TKI maintenance after brexucabtagene autoleucel in Philadelphia chromosome ALL
2026 · Tamer Othman, Gregory W. Roloff, et al. · Blood Advances
Patient Characteristics, Toxicity, and Response after Real World Administration of Obecabtagene Autoleucel and Brexucabtagene Autoleucel for Relapsed Acute Lymphoblastic Leukemia: A Rocca Analysis
2026 · Yannis Valtis, Karamjeet S. Sandhu, et al. · Transplantation and Cellular Therapy
Failed PBSC Mobilization: Combination Dose-Escalated G-CSF + GM-CSF Successfully Rescues Stem Cell Collection and Allows Autologous Transplantation
2026 · Lauren Tryon, Yun Yu, et al. · Transplantation and Cellular Therapy
Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)
2025 · Rawan Faramand, Gregory Roloff, et al. · Transplantation and Cellular Therapy
Retrospective Analysis of Adolescent Young Adult Patients with Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated with the CALGB 10403 Regimen Since Completion of Trial Enrollment
2023 · Brandon DaSilva, Rutu D. Vyas, et al. · Blood
Preoperative Testing and Counseling
2023 · Virginia Tan, Abraham Fridman · Springer eBooks
Works count: 20
Citation count: 56
H-index: 3
I10-index: 1
Year
Topic
Type